Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
academic, acid, acquisition, activist, advantage, advertising, advisory, Albireo, ALBO, arrangement, assert, attempt, Attempting, avoid, bid, bile, BIOD, biotechnology, breach, build, building, call, called, capable, cast, cease, certainty, cGMP, challenged, challenging, charter, choose, circumvented, civil, claim, committee, competition, competitive, competitor, complex, compliance, compromised, confidential, confidentiality, consecutive, consumed, consummated, costly, criteria, cure, curtail, decision, defend, defending, defense, deficiency, deficit, delisted, delisting, deploy, depressing, desirable, desired, difficult, directly, discontinue, discourage, discovery, disgorgement, disproportionately, disruptive, Dissolve, distract, divert, duly, efficacy, embargo, encompassing, enhance, export, extensive, extreme, factual, feasible, fewer, foreign, forfeited, frequently, frustrate, fundraising, gastrointestinal, grace, greater, guarantee, harmed, healthcare, heavily, hired, history, hostile, ideal, impact, impair, impaired, implementing, imposition, improperly, inadvertently, inception, independently, individual, influenced, inherent, intense, intention, interference, interpreted, invalidated, key, kind, labeling, lawsuit, legislation, lengthy, light, likelihood, liver, lose, merging, met, metric, minimum, misappropriated, misappropriation, misleading, monitor, month, movement, narrow, narrowly, nearest, negative, newly, notification, notified, organization, orphan, panel, partner, path, pediatric, person, Pharma, pill, poison, preclude, preliminary, prescribed, prescription, prevent, preventing, priority, promising, promoted, promotion, promotional, proposed, Proposing, prosecuting, proxy, publicly, put, quality, ratio, recall, reconsider, recordkeeping, recruitment, reengineer, refusal, regain, regained, relinquish, remove, renamed, repeal, resolution, responding, restitution, resume, reverse, rounded, royalty, safe, safety, secret, seizure, seller, significantly, single, sought, source, split, stockholder, stopped, strictly, stronger, structure, successfully, supervise, surveillance, suspension, sustainable, symbol, team, testimony, topline, trademark, turn, unanticipated, unauthorized, unfavorable, unrelated, unwarranted, viable, warning, withdrawal
Removed:
absorption, Apidra, application, applying, aspart, automatically, back, blood, characterized, citrate, commence, comparable, comparator, comprised, convenient, delivered, demonstrated, design, dose, ease, EDTA, Eli, eliminate, error, experiencing, face, finalize, formative, formulated, formulation, frequency, glucose, goal, highly, Humalog, hypoglycemia, improvement, indistinguishable, investigational, lead, Lilly, lispro, low, magnesium, needle, Nordisk, Novo, NovoLog, onset, optimizing, pharmacodynamic, pharmacokinetic, Phase, premixed, prolonged, rapid, recombinant, reconstituted, reproducibility, retraction, room, safer, Sanofi, scale, standard, statistically, sulfate, therapeutic, training, uncertain, unmet
Filing tables
Filing exhibits
ALBO similar filings
Filing view
External links
Exhibit 32.01
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Biodel Inc. (the Company ) for the fiscal quarter ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the Report ), the undersigned Gary G. Gemignani, Interim Chief Executive Officer of the Company and Gary G. Gemignani, Chief Financial Officer of the Company, each hereby certifies that: (1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: August 11, 2016 | /s/ Gary G. Gemignani | ||||
| Gary G. Gemignani Interim | |||||
| Chief Executive Officer | |||||
| Dated: August 11, 2016 | /s/ Gary G. Gemignani | ||||
| Gary G. Gemignani, Chief Financial Officer |